Skip to content

Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

Establishment of a Biobank Aimed at Studying Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07265908
Enrollment
3000
Registered
2025-12-05
Start date
2024-04-09
Completion date
2043-12-31
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Infertility, Gynecological Disorders, Male Infertility, Pregnancy

Brief summary

The REPRO-Biobank has been established at San Raffaele Hospital in Milan for the purpose of collecting and preserving human biological samples and associated data. Its primary objective is to support biomedical research, with a particular focus on advancing scientific knowledge - including in the field of genetics - related to gynecological disorders, male and female infertility, and pregnancy-related conditions.

Interventions

OTHERBlood sampling

Blood sampling

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. Affected participants Inclusion Criteria for adult patients (including pregnant and breastfeeding women) and pediatric patients affected by: * Male infertility * Female infertility * Gynecological disorders * Pregnancy-related conditions * Conditions requiring fertility preservation treatment (oocyte cryopreservation, ovarian tissue preservation) * Informed consent signed by the adult patient or by the parents/legal guardians of pediatric patients

Exclusion criteria

* Patients unable or unwilling to sign the informed consent 2. Healthy participants Inclusion Criteria * Healthy adult subjects (including pregnant and lactating women) * Able to give informed consent for participation in the study

Design outcomes

Primary

MeasureTime frame
Developing a biobank/repositoryThrough study completion, an average of 1 year.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026